EdgeNewswire

Inmode Introduces Define: The Revolutionary All-in-One Facial Remodelling Platform

  • 2 min read
  • Inmode

In brief

Inmode announced the launch of Define, a facial-treatment platform intended to combine skin tightening, texture improvement and fat reduction without surgery. The company says the system addresses multiple skin concerns in one platform. Inmode named Lisa Franklin’s skincare clinic in London as its flagship partner. Franklin described the platform as a broad approach to facial remodelling and said the collaboration would pair personalised care with the technology. The release characterizes Define as a non-invasive alternative to surgical procedures, but provides no clinical data or quantified results. Inmode presents the launch as part of its work in aesthetic medicine. The announcement was issued from Rochdale, England, United Kingdom, on December 13, 2023.

Key takeaways

  • Inmode introduced Define, a platform for facial skin tightening, texture improvement and fat reduction.
  • The company says the treatments can be performed simultaneously without surgery.
  • Lisa Franklin’s clinic in London was selected as Define’s flagship partner.
  • The release provides no clinical data or quantified outcome claims.

Inmode, a leader in cutting-edge aesthetic solutions, is proud to announce the launch of Define, its latest innovation in facial remodelling technology.

Rochdale, England, United Kingdom, December 13, 2023 -- This groundbreaking platform is engineered to set new standards in non-invasive skin tightening, textural improvement, and fat reduction.

Define, with its advanced technology, offers a comprehensive approach to facial aesthetics. It targets multiple skin concerns, providing a one-stop solution for those seeking a non-surgical path to a rejuvenated appearance. The platform's versatility lies in its ability to perform skin tightening, textural improvements, and fat reduction simultaneously, making it a unique offering in the aesthetic market.

Inmode has chosen the esteemed Lisa Franklin skincare clinic in London as its flagship partner. Lisa Franklin, renowned for her expertise in skincare and aesthetic treatments, says, “Define by Inmode represents a paradigm shift in facial remodelling. It's not just about enhancing beauty; it's about providing a holistic solution that respects the individuality of each client’s needs.”

This collaboration ensures that clients have access to the best in class service, guided by Lisa Franklin’s expertise. “Our partnership with Inmode enables us to deliver unparalleled results in facial remodelling, combining our commitment to personalised care with the most advanced technology available,” adds Franklin.

Define’s launch is set to revolutionise the aesthetic industry, offering a safe, effective, and non-invasive alternative to traditional surgical procedures. 

With this platform, Inmode continues to demonstrate its commitment to innovation, quality, and customer satisfaction in the realm of aesthetic medicine.

ENDS

About the company: About Inmode: Inmode is a global provider of innovative, life-enhancing medical technologies. With a focus on developing products that deliver exceptional results, Inmode is at the forefront of technological advancements in the aesthetic medicine field. About Lisa Franklin Clinic: Lisa Franklin’s ‘Clinic Privé’ is a premier skin care and aesthetic treatment facility in London, known for its bespoke treatments and commitment to individualised client care.

Contact Info:
Name: Kenza Kettani
Email: Send Email
Organization: inmodemd
Website: https://inmodemd.co.uk/

Social Media:
Facebook: inmodesolutions
Twitter: inmodeuk
Instagram: inmodeuk

If you detect any issues, problems, or errors in this press release content, kindly contact [email protected] to notify us (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). We will respond and rectify the situation in the next 8 hours.

Questions around this news

  1. What treatments is Define designed to provide?

    The release describes Define as a facial-remodelling platform intended to address skin tightening, skin texture and fat reduction. It says the platform can perform these treatments simultaneously and presents it as a non-surgical option. The announcement does not provide clinical evidence, treatment protocols or details about which clients may be suitable.

  2. Where can clients access Define?

    Inmode selected Lisa Franklin’s Clinic Privé in London as the platform’s flagship partner. The release says the collaboration is intended to give clients access to the technology alongside the clinic’s personalised care and aesthetic-treatment expertise. It does not identify other participating clinics or describe plans for wider availability.

  3. What does non-invasive skin tightening mean?

    Non-invasive skin tightening refers generally to treatments intended to improve the appearance of skin firmness without making surgical incisions. Depending on the method, a treatment may use energy or other techniques to affect tissue beneath the skin. The term alone does not establish a particular treatment’s effectiveness, risks, or suitability for an individual.

  4. How does the release characterize Define’s role in facial aesthetics?

    The announcement presents Define as a single platform for several facial-aesthetic goals, rather than a treatment aimed at only one concern. It describes the approach as non-surgical and says the clinic partnership combines the technology with individualised client care. It does not provide comparative results against other treatments or surgical procedures.

Back to News Center
EdgeNewswire

EdgeNewswire distributes your news to a targeted and established network of journalists and media outlets. We help build visibility and credibility for your organization and brand through trusted media coverage.

Copyright © 2024 - 2026   EdgeNewswire – Cutting Edge Press Release Distribution Services. All Rights Reserved.